nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP2C9—Vismodegib—skin cancer	0.129	0.202	CbGbCtD
Hydromorphone—CYP3A4—Imiquimod—skin cancer	0.108	0.169	CbGbCtD
Hydromorphone—CYP3A4—Temozolomide—skin cancer	0.108	0.169	CbGbCtD
Hydromorphone—CYP2D6—Vemurafenib—skin cancer	0.0931	0.146	CbGbCtD
Hydromorphone—CYP3A4—Vismodegib—skin cancer	0.0749	0.117	CbGbCtD
Hydromorphone—CYP3A4—Vemurafenib—skin cancer	0.0592	0.0928	CbGbCtD
Hydromorphone—CYP2C9—Fluorouracil—skin cancer	0.0457	0.0717	CbGbCtD
Hydromorphone—CYP3A4—Docetaxel—skin cancer	0.0203	0.0318	CbGbCtD
Hydromorphone—Migraine—Docetaxel—skin cancer	0.000503	0.00139	CcSEcCtD
Hydromorphone—Urticaria—Imiquimod—skin cancer	0.0005	0.00138	CcSEcCtD
Hydromorphone—Abdominal pain—Imiquimod—skin cancer	0.000498	0.00138	CcSEcCtD
Hydromorphone—Body temperature increased—Imiquimod—skin cancer	0.000498	0.00138	CcSEcCtD
Hydromorphone—Eye disorder—Temozolomide—skin cancer	0.000497	0.00137	CcSEcCtD
Hydromorphone—Tinnitus—Temozolomide—skin cancer	0.000495	0.00137	CcSEcCtD
Hydromorphone—Malaise—Bleomycin—skin cancer	0.000494	0.00137	CcSEcCtD
Hydromorphone—Flushing—Temozolomide—skin cancer	0.000493	0.00136	CcSEcCtD
Hydromorphone—Cardiac disorder—Temozolomide—skin cancer	0.000493	0.00136	CcSEcCtD
Hydromorphone—Leukopenia—Bleomycin—skin cancer	0.000491	0.00136	CcSEcCtD
Hydromorphone—Rhinitis—Fluorouracil—skin cancer	0.000491	0.00136	CcSEcCtD
Hydromorphone—Dizziness—Vemurafenib—skin cancer	0.000488	0.00135	CcSEcCtD
Hydromorphone—Hypoaesthesia—Fluorouracil—skin cancer	0.000487	0.00135	CcSEcCtD
Hydromorphone—Angiopathy—Temozolomide—skin cancer	0.000482	0.00133	CcSEcCtD
Hydromorphone—Immune system disorder—Temozolomide—skin cancer	0.00048	0.00133	CcSEcCtD
Hydromorphone—Mediastinal disorder—Temozolomide—skin cancer	0.000479	0.00132	CcSEcCtD
Hydromorphone—Cough—Bleomycin—skin cancer	0.000478	0.00132	CcSEcCtD
Hydromorphone—Chills—Temozolomide—skin cancer	0.000477	0.00132	CcSEcCtD
Hydromorphone—Dehydration—Docetaxel—skin cancer	0.000475	0.00131	CcSEcCtD
Hydromorphone—Ill-defined disorder—Dactinomycin—skin cancer	0.000474	0.00131	CcSEcCtD
Hydromorphone—Vomiting—Vemurafenib—skin cancer	0.00047	0.0013	CcSEcCtD
Hydromorphone—Chest pain—Bleomycin—skin cancer	0.000467	0.00129	CcSEcCtD
Hydromorphone—Myalgia—Bleomycin—skin cancer	0.000467	0.00129	CcSEcCtD
Hydromorphone—Abdominal pain upper—Docetaxel—skin cancer	0.000466	0.00129	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Docetaxel—skin cancer	0.000466	0.00129	CcSEcCtD
Hydromorphone—Rash—Vemurafenib—skin cancer	0.000466	0.00129	CcSEcCtD
Hydromorphone—Mental disorder—Temozolomide—skin cancer	0.000465	0.00129	CcSEcCtD
Hydromorphone—Dermatitis—Vemurafenib—skin cancer	0.000465	0.00129	CcSEcCtD
Hydromorphone—Hypersensitivity—Imiquimod—skin cancer	0.000464	0.00128	CcSEcCtD
Hydromorphone—Headache—Vemurafenib—skin cancer	0.000463	0.00128	CcSEcCtD
Hydromorphone—Malnutrition—Temozolomide—skin cancer	0.000463	0.00128	CcSEcCtD
Hydromorphone—Erythema—Temozolomide—skin cancer	0.000463	0.00128	CcSEcCtD
Hydromorphone—Breast disorder—Docetaxel—skin cancer	0.000462	0.00127	CcSEcCtD
Hydromorphone—Discomfort—Bleomycin—skin cancer	0.000461	0.00127	CcSEcCtD
Hydromorphone—Malaise—Dactinomycin—skin cancer	0.000461	0.00127	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00046	0.00127	CcSEcCtD
Hydromorphone—Cramp muscle—Docetaxel—skin cancer	0.00046	0.00127	CcSEcCtD
Hydromorphone—Leukopenia—Dactinomycin—skin cancer	0.000458	0.00126	CcSEcCtD
Hydromorphone—Nasopharyngitis—Docetaxel—skin cancer	0.000457	0.00126	CcSEcCtD
Hydromorphone—Dysgeusia—Temozolomide—skin cancer	0.000453	0.00125	CcSEcCtD
Hydromorphone—Asthenia—Imiquimod—skin cancer	0.000452	0.00125	CcSEcCtD
Hydromorphone—Confusional state—Bleomycin—skin cancer	0.000451	0.00125	CcSEcCtD
Hydromorphone—Anaphylactic shock—Bleomycin—skin cancer	0.000447	0.00124	CcSEcCtD
Hydromorphone—Back pain—Temozolomide—skin cancer	0.000447	0.00124	CcSEcCtD
Hydromorphone—Pruritus—Imiquimod—skin cancer	0.000446	0.00123	CcSEcCtD
Hydromorphone—Infection—Bleomycin—skin cancer	0.000445	0.00123	CcSEcCtD
Hydromorphone—Dysphagia—Docetaxel—skin cancer	0.000441	0.00122	CcSEcCtD
Hydromorphone—Nausea—Vemurafenib—skin cancer	0.000439	0.00121	CcSEcCtD
Hydromorphone—Arrhythmia—Fluorouracil—skin cancer	0.000437	0.00121	CcSEcCtD
Hydromorphone—Vision blurred—Temozolomide—skin cancer	0.000436	0.0012	CcSEcCtD
Hydromorphone—Myalgia—Dactinomycin—skin cancer	0.000435	0.0012	CcSEcCtD
Hydromorphone—Bronchospasm—Docetaxel—skin cancer	0.000434	0.0012	CcSEcCtD
Hydromorphone—Tremor—Temozolomide—skin cancer	0.000433	0.0012	CcSEcCtD
Hydromorphone—Diarrhoea—Imiquimod—skin cancer	0.000431	0.00119	CcSEcCtD
Hydromorphone—Discomfort—Dactinomycin—skin cancer	0.00043	0.00119	CcSEcCtD
Hydromorphone—Ill-defined disorder—Temozolomide—skin cancer	0.000429	0.00119	CcSEcCtD
Hydromorphone—Anorexia—Bleomycin—skin cancer	0.000427	0.00118	CcSEcCtD
Hydromorphone—Erythema—Fluorouracil—skin cancer	0.000426	0.00118	CcSEcCtD
Hydromorphone—Agitation—Temozolomide—skin cancer	0.000425	0.00117	CcSEcCtD
Hydromorphone—Angioedema—Temozolomide—skin cancer	0.000423	0.00117	CcSEcCtD
Hydromorphone—Hypotension—Bleomycin—skin cancer	0.000418	0.00116	CcSEcCtD
Hydromorphone—Malaise—Temozolomide—skin cancer	0.000417	0.00115	CcSEcCtD
Hydromorphone—Dizziness—Imiquimod—skin cancer	0.000417	0.00115	CcSEcCtD
Hydromorphone—Vertigo—Temozolomide—skin cancer	0.000416	0.00115	CcSEcCtD
Hydromorphone—Infection—Dactinomycin—skin cancer	0.000415	0.00115	CcSEcCtD
Hydromorphone—Leukopenia—Temozolomide—skin cancer	0.000414	0.00114	CcSEcCtD
Hydromorphone—Palpitations—Temozolomide—skin cancer	0.000409	0.00113	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000408	0.00113	CcSEcCtD
Hydromorphone—Cough—Temozolomide—skin cancer	0.000404	0.00111	CcSEcCtD
Hydromorphone—Paraesthesia—Bleomycin—skin cancer	0.000402	0.00111	CcSEcCtD
Hydromorphone—Vision blurred—Fluorouracil—skin cancer	0.000402	0.00111	CcSEcCtD
Hydromorphone—Convulsion—Temozolomide—skin cancer	0.000401	0.00111	CcSEcCtD
Hydromorphone—Vomiting—Imiquimod—skin cancer	0.0004	0.00111	CcSEcCtD
Hydromorphone—Weight decreased—Docetaxel—skin cancer	0.000399	0.0011	CcSEcCtD
Hydromorphone—Hypertension—Temozolomide—skin cancer	0.000399	0.0011	CcSEcCtD
Hydromorphone—Dyspnoea—Bleomycin—skin cancer	0.000399	0.0011	CcSEcCtD
Hydromorphone—Anorexia—Dactinomycin—skin cancer	0.000398	0.0011	CcSEcCtD
Hydromorphone—Rash—Imiquimod—skin cancer	0.000397	0.0011	CcSEcCtD
Hydromorphone—Dermatitis—Imiquimod—skin cancer	0.000397	0.0011	CcSEcCtD
Hydromorphone—Headache—Imiquimod—skin cancer	0.000395	0.00109	CcSEcCtD
Hydromorphone—Arthralgia—Temozolomide—skin cancer	0.000394	0.00109	CcSEcCtD
Hydromorphone—Myalgia—Temozolomide—skin cancer	0.000394	0.00109	CcSEcCtD
Hydromorphone—Infestation NOS—Docetaxel—skin cancer	0.000394	0.00109	CcSEcCtD
Hydromorphone—Infestation—Docetaxel—skin cancer	0.000394	0.00109	CcSEcCtD
Hydromorphone—Anxiety—Temozolomide—skin cancer	0.000392	0.00108	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000391	0.00108	CcSEcCtD
Hydromorphone—Discomfort—Temozolomide—skin cancer	0.000389	0.00107	CcSEcCtD
Hydromorphone—Decreased appetite—Bleomycin—skin cancer	0.000389	0.00107	CcSEcCtD
Hydromorphone—Dry mouth—Temozolomide—skin cancer	0.000385	0.00106	CcSEcCtD
Hydromorphone—Stomatitis—Docetaxel—skin cancer	0.000384	0.00106	CcSEcCtD
Hydromorphone—Pain—Bleomycin—skin cancer	0.000383	0.00106	CcSEcCtD
Hydromorphone—Leukopenia—Fluorouracil—skin cancer	0.000381	0.00105	CcSEcCtD
Hydromorphone—Confusional state—Temozolomide—skin cancer	0.000381	0.00105	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00038	0.00105	CcSEcCtD
Hydromorphone—Anaphylactic shock—Temozolomide—skin cancer	0.000377	0.00104	CcSEcCtD
Hydromorphone—Infection—Temozolomide—skin cancer	0.000375	0.00104	CcSEcCtD
Hydromorphone—Nausea—Imiquimod—skin cancer	0.000374	0.00103	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Docetaxel—skin cancer	0.000372	0.00103	CcSEcCtD
Hydromorphone—Nervous system disorder—Temozolomide—skin cancer	0.00037	0.00102	CcSEcCtD
Hydromorphone—Convulsion—Fluorouracil—skin cancer	0.000369	0.00102	CcSEcCtD
Hydromorphone—Feeling abnormal—Bleomycin—skin cancer	0.000369	0.00102	CcSEcCtD
Hydromorphone—Skin disorder—Temozolomide—skin cancer	0.000367	0.00101	CcSEcCtD
Hydromorphone—Hyperhidrosis—Temozolomide—skin cancer	0.000365	0.00101	CcSEcCtD
Hydromorphone—Myalgia—Fluorouracil—skin cancer	0.000363	0.001	CcSEcCtD
Hydromorphone—Chest pain—Fluorouracil—skin cancer	0.000363	0.001	CcSEcCtD
Hydromorphone—Decreased appetite—Dactinomycin—skin cancer	0.000363	0.001	CcSEcCtD
Hydromorphone—Fatigue—Dactinomycin—skin cancer	0.00036	0.000994	CcSEcCtD
Hydromorphone—Anorexia—Temozolomide—skin cancer	0.00036	0.000994	CcSEcCtD
Hydromorphone—Discomfort—Fluorouracil—skin cancer	0.000358	0.00099	CcSEcCtD
Hydromorphone—Pain—Dactinomycin—skin cancer	0.000357	0.000986	CcSEcCtD
Hydromorphone—Urticaria—Bleomycin—skin cancer	0.000355	0.000982	CcSEcCtD
Hydromorphone—Rhinitis—Docetaxel—skin cancer	0.000354	0.000979	CcSEcCtD
Hydromorphone—Body temperature increased—Bleomycin—skin cancer	0.000354	0.000977	CcSEcCtD
Hydromorphone—Hypoaesthesia—Docetaxel—skin cancer	0.000352	0.000971	CcSEcCtD
Hydromorphone—Confusional state—Fluorouracil—skin cancer	0.000351	0.000969	CcSEcCtD
Hydromorphone—Urinary tract disorder—Docetaxel—skin cancer	0.000349	0.000964	CcSEcCtD
Hydromorphone—Oedema peripheral—Docetaxel—skin cancer	0.000348	0.000962	CcSEcCtD
Hydromorphone—Anaphylactic shock—Fluorouracil—skin cancer	0.000348	0.000961	CcSEcCtD
Hydromorphone—Connective tissue disorder—Docetaxel—skin cancer	0.000347	0.000959	CcSEcCtD
Hydromorphone—Urethral disorder—Docetaxel—skin cancer	0.000346	0.000957	CcSEcCtD
Hydromorphone—Infection—Fluorouracil—skin cancer	0.000346	0.000955	CcSEcCtD
Hydromorphone—Feeling abnormal—Dactinomycin—skin cancer	0.000344	0.00095	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000344	0.00095	CcSEcCtD
Hydromorphone—Insomnia—Temozolomide—skin cancer	0.000341	0.000943	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000341	0.000943	CcSEcCtD
Hydromorphone—Nervous system disorder—Fluorouracil—skin cancer	0.000341	0.000942	CcSEcCtD
Hydromorphone—Visual impairment—Docetaxel—skin cancer	0.00034	0.000941	CcSEcCtD
Hydromorphone—Tachycardia—Fluorouracil—skin cancer	0.000339	0.000938	CcSEcCtD
Hydromorphone—Paraesthesia—Temozolomide—skin cancer	0.000339	0.000936	CcSEcCtD
Hydromorphone—Dyspnoea—Temozolomide—skin cancer	0.000337	0.00093	CcSEcCtD
Hydromorphone—Somnolence—Temozolomide—skin cancer	0.000336	0.000927	CcSEcCtD
Hydromorphone—Dyspepsia—Temozolomide—skin cancer	0.000332	0.000918	CcSEcCtD
Hydromorphone—Anorexia—Fluorouracil—skin cancer	0.000332	0.000916	CcSEcCtD
Hydromorphone—Eye disorder—Docetaxel—skin cancer	0.00033	0.000912	CcSEcCtD
Hydromorphone—Body temperature increased—Dactinomycin—skin cancer	0.00033	0.000911	CcSEcCtD
Hydromorphone—Abdominal pain—Dactinomycin—skin cancer	0.00033	0.000911	CcSEcCtD
Hydromorphone—Hypersensitivity—Bleomycin—skin cancer	0.00033	0.000911	CcSEcCtD
Hydromorphone—Decreased appetite—Temozolomide—skin cancer	0.000328	0.000906	CcSEcCtD
Hydromorphone—Cardiac disorder—Docetaxel—skin cancer	0.000328	0.000906	CcSEcCtD
Hydromorphone—Flushing—Docetaxel—skin cancer	0.000328	0.000906	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000326	0.0009	CcSEcCtD
Hydromorphone—Fatigue—Temozolomide—skin cancer	0.000325	0.000899	CcSEcCtD
Hydromorphone—Hypotension—Fluorouracil—skin cancer	0.000325	0.000898	CcSEcCtD
Hydromorphone—Pain—Temozolomide—skin cancer	0.000323	0.000892	CcSEcCtD
Hydromorphone—Constipation—Temozolomide—skin cancer	0.000323	0.000892	CcSEcCtD
Hydromorphone—Asthenia—Bleomycin—skin cancer	0.000321	0.000887	CcSEcCtD
Hydromorphone—Angiopathy—Docetaxel—skin cancer	0.000321	0.000886	CcSEcCtD
Hydromorphone—Immune system disorder—Docetaxel—skin cancer	0.000319	0.000882	CcSEcCtD
Hydromorphone—Mediastinal disorder—Docetaxel—skin cancer	0.000318	0.00088	CcSEcCtD
Hydromorphone—Chills—Docetaxel—skin cancer	0.000317	0.000876	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000317	0.000875	CcSEcCtD
Hydromorphone—Pruritus—Bleomycin—skin cancer	0.000317	0.000875	CcSEcCtD
Hydromorphone—Arrhythmia—Docetaxel—skin cancer	0.000316	0.000872	CcSEcCtD
Hydromorphone—Insomnia—Fluorouracil—skin cancer	0.000315	0.000869	CcSEcCtD
Hydromorphone—Paraesthesia—Fluorouracil—skin cancer	0.000312	0.000863	CcSEcCtD
Hydromorphone—Feeling abnormal—Temozolomide—skin cancer	0.000311	0.000859	CcSEcCtD
Hydromorphone—Dyspnoea—Fluorouracil—skin cancer	0.00031	0.000857	CcSEcCtD
Hydromorphone—Mental disorder—Docetaxel—skin cancer	0.00031	0.000855	CcSEcCtD
Hydromorphone—Somnolence—Fluorouracil—skin cancer	0.000309	0.000854	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Temozolomide—skin cancer	0.000309	0.000853	CcSEcCtD
Hydromorphone—Erythema—Docetaxel—skin cancer	0.000308	0.00085	CcSEcCtD
Hydromorphone—Malnutrition—Docetaxel—skin cancer	0.000308	0.00085	CcSEcCtD
Hydromorphone—Hypersensitivity—Dactinomycin—skin cancer	0.000307	0.000849	CcSEcCtD
Hydromorphone—Dyspepsia—Fluorouracil—skin cancer	0.000306	0.000846	CcSEcCtD
Hydromorphone—Decreased appetite—Fluorouracil—skin cancer	0.000302	0.000835	CcSEcCtD
Hydromorphone—Dysgeusia—Docetaxel—skin cancer	0.000301	0.000832	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.0003	0.000829	CcSEcCtD
Hydromorphone—Urticaria—Temozolomide—skin cancer	0.0003	0.000828	CcSEcCtD
Hydromorphone—Asthenia—Dactinomycin—skin cancer	0.000299	0.000827	CcSEcCtD
Hydromorphone—Body temperature increased—Temozolomide—skin cancer	0.000298	0.000824	CcSEcCtD
Hydromorphone—Abdominal pain—Temozolomide—skin cancer	0.000298	0.000824	CcSEcCtD
Hydromorphone—Back pain—Docetaxel—skin cancer	0.000298	0.000822	CcSEcCtD
Hydromorphone—Pain—Fluorouracil—skin cancer	0.000297	0.000822	CcSEcCtD
Hydromorphone—Muscle spasms—Docetaxel—skin cancer	0.000296	0.000817	CcSEcCtD
Hydromorphone—Feeling abnormal—Fluorouracil—skin cancer	0.000287	0.000792	CcSEcCtD
Hydromorphone—Diarrhoea—Dactinomycin—skin cancer	0.000286	0.000789	CcSEcCtD
Hydromorphone—Vomiting—Bleomycin—skin cancer	0.000285	0.000786	CcSEcCtD
Hydromorphone—Rash—Bleomycin—skin cancer	0.000282	0.000779	CcSEcCtD
Hydromorphone—Dermatitis—Bleomycin—skin cancer	0.000282	0.000779	CcSEcCtD
Hydromorphone—Hypersensitivity—Temozolomide—skin cancer	0.000278	0.000768	CcSEcCtD
Hydromorphone—Urticaria—Fluorouracil—skin cancer	0.000276	0.000763	CcSEcCtD
Hydromorphone—Syncope—Docetaxel—skin cancer	0.000276	0.000762	CcSEcCtD
Hydromorphone—Leukopenia—Docetaxel—skin cancer	0.000275	0.000761	CcSEcCtD
Hydromorphone—Body temperature increased—Fluorouracil—skin cancer	0.000275	0.00076	CcSEcCtD
Hydromorphone—Palpitations—Docetaxel—skin cancer	0.000272	0.000751	CcSEcCtD
Hydromorphone—Asthenia—Temozolomide—skin cancer	0.000271	0.000748	CcSEcCtD
Hydromorphone—Loss of consciousness—Docetaxel—skin cancer	0.00027	0.000747	CcSEcCtD
Hydromorphone—Cough—Docetaxel—skin cancer	0.000268	0.000741	CcSEcCtD
Hydromorphone—Pruritus—Temozolomide—skin cancer	0.000267	0.000738	CcSEcCtD
Hydromorphone—Convulsion—Docetaxel—skin cancer	0.000266	0.000736	CcSEcCtD
Hydromorphone—Nausea—Bleomycin—skin cancer	0.000266	0.000734	CcSEcCtD
Hydromorphone—Hypertension—Docetaxel—skin cancer	0.000266	0.000734	CcSEcCtD
Hydromorphone—Vomiting—Dactinomycin—skin cancer	0.000265	0.000733	CcSEcCtD
Hydromorphone—Rash—Dactinomycin—skin cancer	0.000263	0.000727	CcSEcCtD
Hydromorphone—Chest pain—Docetaxel—skin cancer	0.000262	0.000723	CcSEcCtD
Hydromorphone—Myalgia—Docetaxel—skin cancer	0.000262	0.000723	CcSEcCtD
Hydromorphone—Arthralgia—Docetaxel—skin cancer	0.000262	0.000723	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00026	0.000718	CcSEcCtD
Hydromorphone—Diarrhoea—Temozolomide—skin cancer	0.000258	0.000713	CcSEcCtD
Hydromorphone—Hypersensitivity—Fluorouracil—skin cancer	0.000256	0.000708	CcSEcCtD
Hydromorphone—Dry mouth—Docetaxel—skin cancer	0.000256	0.000707	CcSEcCtD
Hydromorphone—Confusional state—Docetaxel—skin cancer	0.000253	0.000699	CcSEcCtD
Hydromorphone—Anaphylactic shock—Docetaxel—skin cancer	0.000251	0.000693	CcSEcCtD
Hydromorphone—Dizziness—Temozolomide—skin cancer	0.00025	0.00069	CcSEcCtD
Hydromorphone—Infection—Docetaxel—skin cancer	0.000249	0.000689	CcSEcCtD
Hydromorphone—Nausea—Dactinomycin—skin cancer	0.000248	0.000685	CcSEcCtD
Hydromorphone—Shock—Docetaxel—skin cancer	0.000247	0.000682	CcSEcCtD
Hydromorphone—Nervous system disorder—Docetaxel—skin cancer	0.000246	0.00068	CcSEcCtD
Hydromorphone—Pruritus—Fluorouracil—skin cancer	0.000246	0.00068	CcSEcCtD
Hydromorphone—Tachycardia—Docetaxel—skin cancer	0.000245	0.000677	CcSEcCtD
Hydromorphone—Skin disorder—Docetaxel—skin cancer	0.000244	0.000674	CcSEcCtD
Hydromorphone—Vomiting—Temozolomide—skin cancer	0.00024	0.000663	CcSEcCtD
Hydromorphone—Anorexia—Docetaxel—skin cancer	0.000239	0.000661	CcSEcCtD
Hydromorphone—Rash—Temozolomide—skin cancer	0.000238	0.000657	CcSEcCtD
Hydromorphone—Diarrhoea—Fluorouracil—skin cancer	0.000238	0.000657	CcSEcCtD
Hydromorphone—Dermatitis—Temozolomide—skin cancer	0.000238	0.000657	CcSEcCtD
Hydromorphone—Headache—Temozolomide—skin cancer	0.000236	0.000653	CcSEcCtD
Hydromorphone—Hypotension—Docetaxel—skin cancer	0.000235	0.000648	CcSEcCtD
Hydromorphone—Dizziness—Fluorouracil—skin cancer	0.00023	0.000635	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000229	0.000632	CcSEcCtD
Hydromorphone—Insomnia—Docetaxel—skin cancer	0.000227	0.000627	CcSEcCtD
Hydromorphone—Paraesthesia—Docetaxel—skin cancer	0.000225	0.000623	CcSEcCtD
Hydromorphone—Nausea—Temozolomide—skin cancer	0.000224	0.000619	CcSEcCtD
Hydromorphone—Dyspnoea—Docetaxel—skin cancer	0.000224	0.000618	CcSEcCtD
Hydromorphone—Somnolence—Docetaxel—skin cancer	0.000223	0.000616	CcSEcCtD
Hydromorphone—Vomiting—Fluorouracil—skin cancer	0.000221	0.000611	CcSEcCtD
Hydromorphone—Dyspepsia—Docetaxel—skin cancer	0.000221	0.00061	CcSEcCtD
Hydromorphone—Rash—Fluorouracil—skin cancer	0.000219	0.000606	CcSEcCtD
Hydromorphone—Dermatitis—Fluorouracil—skin cancer	0.000219	0.000605	CcSEcCtD
Hydromorphone—Decreased appetite—Docetaxel—skin cancer	0.000218	0.000603	CcSEcCtD
Hydromorphone—Headache—Fluorouracil—skin cancer	0.000218	0.000602	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Docetaxel—skin cancer	0.000217	0.000599	CcSEcCtD
Hydromorphone—Fatigue—Docetaxel—skin cancer	0.000216	0.000598	CcSEcCtD
Hydromorphone—Pain—Docetaxel—skin cancer	0.000215	0.000593	CcSEcCtD
Hydromorphone—Constipation—Docetaxel—skin cancer	0.000215	0.000593	CcSEcCtD
Hydromorphone—Feeling abnormal—Docetaxel—skin cancer	0.000207	0.000571	CcSEcCtD
Hydromorphone—Nausea—Fluorouracil—skin cancer	0.000207	0.000571	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Docetaxel—skin cancer	0.000205	0.000567	CcSEcCtD
Hydromorphone—Abdominal pain—Docetaxel—skin cancer	0.000198	0.000548	CcSEcCtD
Hydromorphone—Body temperature increased—Docetaxel—skin cancer	0.000198	0.000548	CcSEcCtD
Hydromorphone—Hypersensitivity—Docetaxel—skin cancer	0.000185	0.000511	CcSEcCtD
Hydromorphone—Asthenia—Docetaxel—skin cancer	0.00018	0.000498	CcSEcCtD
Hydromorphone—Pruritus—Docetaxel—skin cancer	0.000178	0.000491	CcSEcCtD
Hydromorphone—Diarrhoea—Docetaxel—skin cancer	0.000172	0.000474	CcSEcCtD
Hydromorphone—Dizziness—Docetaxel—skin cancer	0.000166	0.000459	CcSEcCtD
Hydromorphone—Vomiting—Docetaxel—skin cancer	0.00016	0.000441	CcSEcCtD
Hydromorphone—Rash—Docetaxel—skin cancer	0.000158	0.000437	CcSEcCtD
Hydromorphone—Dermatitis—Docetaxel—skin cancer	0.000158	0.000437	CcSEcCtD
Hydromorphone—Headache—Docetaxel—skin cancer	0.000157	0.000434	CcSEcCtD
Hydromorphone—Nausea—Docetaxel—skin cancer	0.000149	0.000412	CcSEcCtD
